None listed
Conditions
Interventions
None listed
Sponsors
Chaudhary Brahm Prakash Ayurveda Charak Sansthan
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals of either sex aged 30-50 years irrespective of their occupation and socioeconomic status 2. Individuals having LDL more than 150mg/dl or ? Total cholesterol more than 250mg/dl - 270mg/dl 3. Willing and able to participate for 9 weeks 4. Individuals with informed consent 5.obese patient -BMI more than 25 6.pre hypertensive patient [BP more than 140/80 mmHg ]-not on medication 7.patient having complaint of headache 8.sedentary lifestyle 9.Individuals whose having rasadhatu dushti.
Exclusion criteria
Exclusion criteria: 1. Individuals who have received any medicines related to cardiac disorders(Modern Drug) within last 8 weeks. 2. Individuals having Type III and Type IV hypercholesterolaemia. 3. Individuals with poorly controlled Hypertension (more than 160 / 100 mm Hg). 4. Individuals with evidence of malignancy. 5. Individuals on prolonged (more than 6 weeks) medication with antidepressants, corticosteoids, anticholinergics, immunosuppressants, oral contraceptive pills or estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study. 6. Individuals suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders, etc.). 7. Individuals who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months. 8. Symptomatic patient with clinical evidence of Heart failure. 9. Individuals having uncontrolled Diabetes Mellitus i.e HbA1c more than 10%. 10. Individuals with concurrent serious hepatic disorder (defined as aspartate aminotransferase (AST) and / or alanine aminotransferase (ALT), total bilirubin or alkaline phosphatase (ALP) more than 2 times upper normal limit) or renal disorders (defined as S.creatinine more than 1.2mg/dl), severe pulmonary dysfunction (uncontrolled asthma and chronic obstructive pulmonary disease [COPD]), inflammatory bowel disease or any other condition that may jeopardize the study. 11. Pregnant/ lactating females. 12. Individuals on oral contraceptives. 13. Alcoholics and/or drug abusers. 14. H/o hypersensitivity to any of the trial drugs or their ingredients. 15. Individuals who have completed participation in any other clinical trial during the past six (06) months. Any other condition which the Principal Investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the efficacy of AMLAKI CHURNA in preventing HRIDYA ROGATimepoint: 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life[SF-36] Improvement in assessment criteria[RAS-RCVD SCALE] Improvement in deranged lipid profile.Timepoint: 60 Days | — |
Countries
India
Contacts
Public ContactDr rakesh kumar verma
Chaudhary Brahm Prakash Ayurved Charak Sansthan
Outcome results
None listed